Skip to main content
Premium Trial:

Request an Annual Quote

UT Arlington Scientist Nabs $600K for Fruit Fly Database

NEW YORK (GenomeWeb) – Researchers at the University of Texas at Arlington have received a $600,000 grant from the National Science Foundation to create an interactive database of fruit fly gene expression.

Associate Professor Heng Huang and Professor Chris Ding in the UT Arlington Computer Science and Engineering Department hope that the database will result in new methods for analyzing Drosophila gene expression data that could be useful in a range of research disciplines, including systems biology, oncology, clinical pathology, and pharmaceuticals.

"We're building a system through which the computer will recognize what happens in these fruit fly genes and how the genes then interact with each other,” Huang said in a statement.

“Because so many of the genes involved in fruit fly development are found in humans and other species, finding out what these expressions are and how they work with each other is highly important," he said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.